Ballicules.com

Chlorthalidone

THALITONE

What it isThiazide-like NCC inhibitor; hypertension and edema.

Why this oneIts longer action and stronger outcomes evidence distinguish it from hydrochlorothiazide.

What limits itHyponatremia and hypokalemia are more pronounced than with hydrochlorothiazide; monitor electrolytes and renal function.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
HypertensionAdults25 mg QD (morning)25–50 mg QD100 mg/day (>100 no added benefit)
EdemaAdults50–100 mg QD or 100 mg every other day50–200 mg QD or alternate days200 mg/day

Titration Increase after a suitable trial if response insufficient

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Category B; use only if clearly needed — thiazides cross placenta (risk fetal/neonatal jaundice, thrombocytopenia)

Lactation Undefined

NO BOXED WARNINGS

Principal riskHyponatremia and hypokalemia; longer-acting than hydrochlorothiazide

Cost, est. cash$5–$150/month

Generic entry1982

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityHyponatremia, hypokalemia and substantial elevation of lithium concentrations.

Mechanism of action: Chlorthalidone ballicule

Chlorthalidone ballicule: receptor binding, kinetics and half-life diagram

Open Chlorthalidone in the interactive console ↗

Memory aids: mascots and interaction avatars

Chlorthalidone THALITONE mascot mnemonic cartoon
“Cooler thiazide, lid on”
Bananas dispersing → ↓ serum potassium
Chlorthalidone Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Chlorthalidone in the interactive console ↗